Cite
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?
MLA
Wingard, John R., et al. “Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?” Open Forum Infectious Diseases, vol. 8, no. 10, Oct. 2021, pp. 1–7. EBSCOhost, https://doi.org/10.1093/ofid/ofab441.
APA
Wingard, J. R., Alexander, B. D., Baden, L. R., Chen, M., Sugrue, M. W., Leather, H. L., Caliendo, A. M., Clancy, C. J., Denning, D. W., Marty, F. M., Nguyen, M. H., Wheat, L. J., Logan, B. R., Horowitz, M. M., & Marr, K. A. (2021). Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials? Open Forum Infectious Diseases, 8(10), 1–7. https://doi.org/10.1093/ofid/ofab441
Chicago
Wingard, John R, Barbara D Alexander, Lindsey R Baden, Min Chen, Michele W Sugrue, Helen L Leather, Angela M Caliendo, et al. 2021. “Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?” Open Forum Infectious Diseases 8 (10): 1–7. doi:10.1093/ofid/ofab441.